Mechanisms of Wnt/beta-catenin inhibition by resveratrol and its derivatives
白藜芦醇及其衍生物抑制Wnt/β-catenin的机制
基本信息
- 批准号:8191422
- 负责人:
- 金额:$ 16.15万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2011
- 资助国家:美国
- 起止时间:2011-08-10 至 2013-07-31
- 项目状态:已结题
- 来源:
- 关键词:APC geneAccountingAdenomatous Polyposis ColiBiological FactorsBiometryBlueberriesCTNNB1 geneCancer CenterCancer EtiologyCancer ModelCell ProliferationCell modelCessation of lifeChemicalsChemopreventionChemopreventive AgentClinicalClinical ResearchColitisColonColon CarcinomaColorectal CancerDimethylhydrazinesExhibitsFutureGenesGoalsGrapesGrowthHandIn VitroInflammationInterdisciplinary StudyLeadMalignant NeoplasmsModelingModificationMolecularMolecular TargetMusMutationNew AgentsNude MicePathologyPathway interactionsPharmaceutical PreparationsPhysiciansPlantsProteomicsPublicationsResearchResveratrolSignal TransductionSkinStagingStilbenesTestingToxic effectUnited StatesUniversitiesWorkXenograft procedureadenomaanalogbasebeta cateninbioactive food componentcancer cellcancer chemopreventioncancer preventioncancer therapycolon carcinogenesiscolorectal cancer preventiondesignin vivoinhibitor/antagonistinsightmortalitymouse modelnovelphytoalexinphytoalexinspreventred wineresponsetrans-resveratroltumortumor growth
项目摘要
DESCRIPTION (provided by applicant): This is a revised application in response to PA-10-088, "Exploratory Cancer Prevention Studies Involving Molecular Targets for Bioactive Food Components (R21)". In this project, we will characterize a novel molecular target of resveratrol for colorectal cancer prevention. Colorectal cancer is the second leading cause of cancer-related mortality in the United States and accounts for more than 56,000 deaths per year. Colorectal cancer is initiated by mutations of adenomatous polyposis coli (APC) and 2-catenin genes, which result in abnormal activation of Wnt signaling. Inhibition Wnt signaling is essential for colorectal cancer chemoprevention. Resveratrol is found in the skin of red grape and also present in the red wine. Resveratrol and many of its analogs have anti-cancer activity. We found several resveratrol analogs, including pterostilbene found in blueberry, can strongly inhibit Wnt signaling, while cis-resveratrol cannot. We have designed and synthesized a panel of novel resveratrol analogs and have identified several novel inhibitors for Wnt/2-catenin signaling. Our central hypothesis is that resveratrol and its analogs inhibit Wnt signaling, thus prevent of 2-catenin-induced cancers, particularly colorectal cancers. To further understand the molecular mechanisms of resveratrol in Wnt/2-catenin inhibition and to develop better inhibitors for chemoprevention, we will pursue the following two specific aims: 1) to delineate the mechanisms of how resveratrol inhibits Wnt signaling using cell models; and 2) to investigate how resveratrol and its analogs inhibits Wnt signaling using a novel inflammation-related mouse colon cancer model.
PUBLIC HEALTH RELEVANCE: Colorectal cancer is the second leading cause of cancer death in the United States. This project is to explore a novel mechanism of cancer prevention by resveratrol, a product from red grapes. We found that resveratrol blocks Wnt signaling, a key pathway in colon cancer formation. The studies in this project will provide a better understanding of resveratrol function in cancer prevention and will lead to better chemoprevention agents in the future.
描述(由申请人提供):这是对PA-10-088的修订应用,“涉及生物活性食品成分分子靶标(R21)的探索性癌症预防研究”。在这个项目中,我们将表征用于预防大肠癌的白藜芦醇的新型分子靶标。大肠癌是美国与癌症相关死亡率的第二大原因,每年造成56,000多人死亡。结直肠癌是由腺瘤性息肉病(APC)和2-catenin基因的突变引发的,这导致Wnt信号的异常激活。抑制Wnt信号对于结直肠癌化学预防至关重要。白藜芦醇在红葡萄的皮肤中发现,也存在于红酒中。白藜芦醇及其许多类似物具有抗癌活性。我们发现几种白藜芦醇类似物,包括在蓝莓中发现的翼龙,可以强烈抑制Wnt信号传导,而顺式白藜芦醇则不能。我们设计并合成了一系列新型白藜芦醇类似物,并确定了Wnt/2-catenin信号传导的几种新型抑制剂。我们的中心假设是白藜芦醇及其类似物抑制了Wnt信号传导,从而阻止了2-Catenin诱导的癌症,尤其是结直肠癌。为了进一步了解白藜芦醇在Wnt/2-catenin抑制中的分子机制,并为化学预防开发更好的抑制剂,我们将追求以下两个具体目的:1)描述白藜芦醇如何使用细胞模型抑制Wnt信号的机制; 2)研究白藜芦醇及其类似物如何使用新型炎症相关的小鼠结肠癌模型抑制Wnt信号传导。
公共卫生相关性:大肠癌是美国癌症死亡的第二大原因。该项目是为了探索红葡萄产物的白藜芦醇预防癌症预防的新机制。我们发现白藜芦醇阻止了Wnt信号传导,这是结肠癌形成的关键途径。该项目中的研究将更好地了解预防癌症中的白藜芦醇功能,并将在未来提供更好的化学预防剂。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
CHUNMING LIU其他文献
CHUNMING LIU的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('CHUNMING LIU', 18)}}的其他基金
Novel resveratrol analogs and colorectal cancer treatment
新型白藜芦醇类似物和结直肠癌治疗
- 批准号:
8715739 - 财政年份:2013
- 资助金额:
$ 16.15万 - 项目类别:
Novel resveratrol analogs and colorectal cancer treatment
新型白藜芦醇类似物和结直肠癌治疗
- 批准号:
8847232 - 财政年份:2013
- 资助金额:
$ 16.15万 - 项目类别:
Novel resveratrol analogs and colorectal cancer treatment
新型白藜芦醇类似物和结直肠癌治疗
- 批准号:
8576714 - 财政年份:2013
- 资助金额:
$ 16.15万 - 项目类别:
Mechanisms of Wnt/beta-catenin inhibition by resveratrol and its derivatives
白藜芦醇及其衍生物抑制Wnt/β-catenin的机制
- 批准号:
8318099 - 财政年份:2011
- 资助金额:
$ 16.15万 - 项目类别:
GKLF/Beta-catenin crosstalk in the intestine
GKLF/β-连环蛋白在肠道中的串扰
- 批准号:
7638597 - 财政年份:2007
- 资助金额:
$ 16.15万 - 项目类别:
GKLF/Beta-catenin crosstalk in the intestine
GKLF/β-连环蛋白在肠道中的串扰
- 批准号:
7985874 - 财政年份:2007
- 资助金额:
$ 16.15万 - 项目类别:
GKLF/Beta-catenin crosstalk in the intestine
GKLF/β-连环蛋白在肠道中的串扰
- 批准号:
8107647 - 财政年份:2007
- 资助金额:
$ 16.15万 - 项目类别:
GKLF/Beta-catenin crosstalk in the intestine
GKLF/β-连环蛋白在肠道中的串扰
- 批准号:
7197425 - 财政年份:2007
- 资助金额:
$ 16.15万 - 项目类别:
GKLF/Beta-catenin crosstalk in the intestine
GKLF/β-连环蛋白在肠道中的串扰
- 批准号:
7490008 - 财政年份:2007
- 资助金额:
$ 16.15万 - 项目类别:
Beta-catenin regulation by tumor suppressor APC
抑癌基因 APC 对 β-连环蛋白的调节
- 批准号:
7001272 - 财政年份:2005
- 资助金额:
$ 16.15万 - 项目类别:
相似国自然基金
签字注册会计师动态配置问题研究:基于临阵换师视角
- 批准号:72362023
- 批准年份:2023
- 资助金额:28 万元
- 项目类别:地区科学基金项目
全生命周期视域的会计师事务所分所一体化治理与审计风险控制研究
- 批准号:72372064
- 批准年份:2023
- 资助金额:40 万元
- 项目类别:面上项目
会计师事务所数字化能力构建:动机、经济后果及作用机制
- 批准号:72372028
- 批准年份:2023
- 资助金额:42.00 万元
- 项目类别:面上项目
会计师事务所薪酬激励机制:理论框架、激励效应检验与优化重构
- 批准号:72362001
- 批准年份:2023
- 资助金额:28.00 万元
- 项目类别:地区科学基金项目
环境治理目标下的公司财务、会计和审计行为研究
- 批准号:72332002
- 批准年份:2023
- 资助金额:165.00 万元
- 项目类别:重点项目
相似海外基金
Next generation sequencing to identify novel colorectal cancer genes
下一代测序鉴定新的结直肠癌基因
- 批准号:
8862434 - 财政年份:2014
- 资助金额:
$ 16.15万 - 项目类别:
Next generation sequencing to identify novel colorectal cancer genes
下一代测序鉴定新的结直肠癌基因
- 批准号:
8697393 - 财政年份:2014
- 资助金额:
$ 16.15万 - 项目类别:
Novel resveratrol analogs and colorectal cancer treatment
新型白藜芦醇类似物和结直肠癌治疗
- 批准号:
8715739 - 财政年份:2013
- 资助金额:
$ 16.15万 - 项目类别:
Novel resveratrol analogs and colorectal cancer treatment
新型白藜芦醇类似物和结直肠癌治疗
- 批准号:
8847232 - 财政年份:2013
- 资助金额:
$ 16.15万 - 项目类别:
Novel resveratrol analogs and colorectal cancer treatment
新型白藜芦醇类似物和结直肠癌治疗
- 批准号:
8576714 - 财政年份:2013
- 资助金额:
$ 16.15万 - 项目类别: